isatin has been researched along with Metastase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hou, L; Ju, C; Sun, W; Wei, Y; Zhang, L; Zhao, S | 1 |
Abid, M; Alajmi, MF; Ali, S; Aneja, B; El-Seedi, HR; Hassan, MI; Hussain, A; Khan, NS; Khan, P; Queen, A; Rehman, MT | 1 |
2 other study(ies) available for isatin and Metastase
Article | Year |
---|---|
Isatin inhibits SH-SY5Y neuroblastoma cell invasion and metastasis through MAO/HIF-1α/CXCR4 signaling.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isatin; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neoplasm Metastasis; Neuroblastoma; Reactive Oxygen Species; Receptors, CXCR4; Signal Transduction | 2017 |
Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Hep G2 Cells; Humans; Hydrazones; Isatin; MCF-7 Cells; Neoplasm Metastasis; Oxidative Stress; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Triazoles | 2019 |